Emergent BioSolutions Inc. — Director's Dealing 2020

Apr 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-04-06

Reporting Person: Kirk Sean (EVP, Manufacturing & Tech Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-06	Common Stock	S	5666	$60	Disposed	12571	Direct
2020-04-06	Common Stock	M	3135	$30.86	Acquired	15706	Direct
2020-04-06	Common Stock	S	3135	$60	Disposed	12571	Direct
2020-04-06	Common Stock	M	7293	$30.63	Acquired	19864	Direct
2020-04-06	Common Stock	S	7293	$60	Disposed	12571	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-06	Employee Stock Options (Right to Buy)	$30.86	S	3135	Disposed	2021-02-28	Employee Stock Options (Right to Buy) (3135.0)	Direct
2020-04-06	Employee Stock Options (Right to Buy)	$30.63	S	7293	Disposed	2022-02-27	Employee Stock Options (Right to Buy) (7293.0)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk.

F2: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.

F3: The options vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company.